APTO
Aptose Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.36M
P/E Ratio
—
EPS
$-36.38
Beta
1.13
52W High
$0.00
52W Low
$0.00
50-Day MA
$3.60
200-Day MA
$8.76
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Aptose Biosciences Inc
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies that address unmet medical needs in oncology in the United States. The company is headquartered in Toronto, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-36.15M |
| Operating Margin | 0.00% |
| Return on Equity | -694.00% |
| Return on Assets | -142.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-14.04 |
| Price-to-Book | 67.84 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.05 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $2.55M |
| Float | 499,770 |
| % Insiders | 24.80% |
| % Institutions | 11.51% |
Data last updated: 4/7/2026